CO LTD Research Articles

Shenzhen Catalyst Petrochemical CO LTD expands partnership with CNOOC & Shell Petrochemical Co Ltd

Shenzhen Catalyst Petrochemical CO LTD expands partnership with CNOOC & Shell Petrochemical Co Ltd

COMPARISONS OF STANDARDS OF LIQUID CONSUMPTION UNITS AS AN EFFECTIVE MEASURE TO ENSURE THE UNIFORMITY OF MEASUREMENTS WHEN TAKING INTO ACCOUNT RESOURCES IN THE SYSTEMS OF HEAT AND WATER SUPPLY

Rational use of resources in heat and water supply systems and other industries is impossible without reliable measurement results of fluid consumption. The reliability of the measurement results is confirmed by their traceability to national standards. To ensure the traceability of flow standards, which cannot be directly connected to the national standard, it is necessary to carry out a comparison using a transfer standard. The main results of interlaboratory comparisons of fluid flow standards are considered. Comparisons, the pilot laboratory of which was State Enterprise "Ukrmetrteststandart", carried out with the participation of Firm "Sempal CO LTD", Kiev. The aim of the project was to carry out comparisons in the field of flow measurements between water meter calibration laboratories. Based on the results of comparisons, it was established: there are no significant deviations of the real parameters from those specified in the instructions; according to the agreed range of comparisons for flow rates from 13 m3/h to 350 m3/h, all the results of the installations are in good agreement; degree of equivalence "Laboratory to CRV" and "Laboratory to laboratory" Ei ≤ 1, laboratories are in good agreement; all results are completely satisfactory with a degree of equivalence less than 1.

Correlation Between Postoperative Central Corneal Thickness and Endothelial Damage After Cataract Surgery by Phacoemulsification.

To study the correlation between postoperative corneal edema and endothelial cell loss after cataract surgery by microcoaxial phacoemulsification. Eighty-five eyes of 85 consecutive patients with mild cataract (up to C5, N4, and P5: per LOCS III classification) were included in a prospective study from September 2014 to November 2014. Eighty-five eyes were necessary to obtain a precision of 0.15 for computation of the Pearson correlation coefficient. Pachymetry and endothelial cell density measurements were taken preoperatively, 2 hours after surgery, and 4 days, 15 days, and 1 month after surgery using CEM-530 noncontact specular microscopy (Nidek CO Ltd, Japan). Every surgery was performed using the Stellaris device (Bausch & Lomb, Bridgewater, NJ) in a microcoaxial mode with 2.2-mm incisions. Mean age was 73 ± 2.1 years, with 41 women (48%) and 44 men (52%). The mean surgical time was 8 ± 5.5 minutes, and the mean effective phacoemulsification time was 7 ± 3.7 seconds. Mean central corneal thickness augmentation was 46.68 ± 10 μm (8.39%) 2 hours after surgery, 10 ± 18 μm (1.8%) 4 days after surgery, and only 0.76 ± 11.4 μm (0.1%) 15 days after surgery. Mean endothelial cell loss was 3.0 ± 1.5% at 2 hours, 9.0 ± 3.3% at D4, 10 ± 4.6% at D15, and 11 ± 4.7% at 1 month. At D4, significant endothelial loss (>15%) was mostly related to significant immediate corneal edema (>15%), whereas low postoperative edema (<5%) did not lead to significant endothelial loss (loss <5%). At D15 and D30, endothelial cell loss seemed to be closely correlated with immediate postoperative edema (Pearson correlation coefficient between central corneal edema at H2 and endothelial cells loss at 1 month: r = 0.4, P < 0.0001). Postoperative corneal thickness measurement may therefore become a marker of endothelial damage after phacoemulsification.

Enrich Energy America LLC of Salt Lake City, US selects TSM TECH CO LTD of South Korea to become its lead fabricator for refineries and new catalytic hydrogen systems

Enrich Energy America LLC of Salt Lake City, US selects TSM TECH CO LTD of South Korea to become its lead fabricator for refineries and new catalytic hydrogen systems

Neovaskulinės amžinės geltonosios dėmės degeneracijos gydymo ranibizumabu 24 mėnesių morfologiniai ir funkciniai pokyčiai

Key words: ranibizumab, age-related macular degeneration, central macular thickness. Research objective. To evaluate influence of treatment with vascular endothelial growth factor inhibitor, ranibizumab, for best corrected visual acuity and central macular thickness in patients with neovascular age-related macular degeneration. Materials and methods. In this retrospective study were included treatment – naive patients. Intravitreal injections were performed at Lithuanian University of Health Sciences Kaunas Clinics Eye clinic. In this study were analysed the 24-month morphological and functional outcomes of intravitreal ranibizumab injections. Best corrected visual acuity was meassured using the Snellen chart (Landolt’s rings C optotypes). Optical coherence tomography images were obtained using the spectral – domain OCT (NIDEK RS – 3000 Advance (NIDEK CO LTD, Japan). The central thickness measurements were obtained from macular thickness maps using the digital caliper tool. Results. In this study were included 88 patients. Best corrected visual acuity before treatment was 0.36 ± 0.22. The difference between visual acuity before and after first injection was 0.04 ± 0.22 (p = 0.03). Before fifth injection visual acuity was 0.41 ± 0.21, after – 0.46 ± 0.22 (p = 0.05). Central macular thickness before treatment was 297.81 ± 106.04 μm. The difference between central macular thickness before and after first injection was 85.21 ± 113.37 μm (p &amp;lt; 0.001). Before second injection central macular thickness was 273.57 ± 87.49 μm, after – 234.51 ± 58.96 μm (p = 0.002). Before fourth injection central macular thickness was 237.20 ± 40.87 μm, after – 219.10 ± 42.26 μm (p = 0.04). The mean central macular thickness significantly decreased from 298.15 ± 104.78 to 229.08 ± 56.57 (p &amp;lt; 0.001). In 24 month of treatment the average number of ranibizumab injections was 3.61 ± 1.55. Conclusions. Our study’s results showed that over 24 month best corrected visual acuity improvement was statistically significant after first and fifth injection. Baseline compared with last injection, there was not statistically significant difference. Central macular thickness improvement statistically significant was after first, second and fourth injection. There was statistically significant decreased baseline compared with the last injection. The mean number of ranibizumab injections was 3.61 ± 1.55 in 24 month.

Intraoperative placement of transnasal small intestinal feeding tube during the surgery in 5 cases with high position intestinal obstruction and postoperative feeding

To explore the value of employing the small intestinal feeding tube in treating high position intestinal obstruction of newborn infant. Five newborn infants (3 males and 2 females; 1 premature infant and 4 fully-mature infants; 2 had membranous atresia of duodenum, 1 had annular pancreas, and 2 had proximal small intestine atresia; 1 infant had malrotation). The duodenal membrane-like atresia and the blind-end of small intestine were removed and intestinal anastomosis was performed, which was combined with intestinal malrotation removal. Before the intestinal anastomosis surgery, the anesthetist inserted via nose a 6Fr small intestinal ED tube, made by CREATE MEDIC CO LTD of Japan[ the State Food and Drug Administration-instrument (Im.) 2007-NO.2661620]. Twenty-four hours after surgery, abdominal X-ray plain film was taken and patients were fed with syrup; 48 hours later, formula milk was pumped or lactose-free milk amino acids were given by intravenous injection pump through the feeding tube. The amount of milk and fluids was gradually increased to normal amount according to the condition. In initial 3 days the intravenous nutrition was given and one week after operation, the infants were fed through mouth in addition to pumping milk through the tube and stopped infusion. Ten to 22 days after operation, the tube was removed and the infant patients were discharged. All the five infants showed that the feeding through the nutrition tube was accomplished and the time of venous nutrition was reduced and fistula operation was avoided. None of the infants on question was off the tube and no jaundice exacerbation was found and the liver function was also found normal. At the very beginning, the tube was occasionally blocked by milk vale in one infant and after 0.9% sodium chloride solution flushing patency restored. After that, the feeding tube was washed once with warm water after feeding. In one infant vomiting occurred due to enough oral milk. The photograph of upper gastrointestine did not show anastomomotic stricture or fistula, or intestinal obstruction. After pulling out the tube, the symptoms disappeared and then the patient was discharged. One child was found to have diarrhea with no lactose nutrition liquid and given compound lactic bacteria preparations for oral administration, the symptom disappeared. In the 5 cases, the shortest hospital stay was 10 days and the longest was 22 days, the average stay was 16 days. Three to 5 days after operation the weight restored to birth weight, the weight had increased, when discharged, to an average of 5.5 g (kg·d). The small intestinal feeding tube was very effective for the postoperative nutrition maintenance of high position intestinal obstruction in newborn infants.

Research on Innovation Mechanism and Model of Logistics Enterprise

As a new field in the service industry, logistics is growing rapidly and is regarded as a fundamental industry in a national economy. Its development is an important symbol of a country’s modernization and national strength. It also works as an accelerator in economic development. At the initial stage of transforming traditional logistics service to a modern logistics service in China, logistics enterprises have encountered many difficulties and problems including an imbalanced supply and demand, distempered industrial structure, faultiness of serving process and backwardness of logistics technology since 2005.Compared with developed countries, there is a great gap between Chinese logistics enterprises and advanced countries’ in the aspects of service concepts, model, and content and techniques. Therefore, based on the service innovation driving model theory, the authors analyze the integrated innovation model of logistics enterprises, logistics technology and network model, and the value-added service model. The authors select Shenzhen China Overseas Logistics Co. LTD (COL) as the empirical object to analyze its operation of technology and non-technology innovation and summarize its inner and outer driving force on promoting service innovation.

DR REDDY'S LABORATORIES (UK) LTD v ELI LILLY AND CO LTD

DR REDDY’S LABORATORIES (UK) LTD v ELI LILLY AND CO LTD Get access Reports of Patent, Design and Trade Mark Cases, Volume 127, Issue 3, March 2010, Pages 222–255, https://doi.org/10.1093/rpc/rcq020 Published: 01 March 2010

LG PHILIPS LCD CO LTD v TATUNG (UK) LTD

LG PHILIPS LCD CO LTD v TATUNG (UK) LTD Get access Reports of Patent, Design and Trade Mark Cases, Volume 124, Issue 13-14, 2007, Pages 509–526, https://doi.org/10.1093/rpc/2007rpc21 Published: 01 July 2007

NAVITAIRE INC v EASYJET AIRLINE CO LTD (NO.2)

Journal Article NAVITAIRE INC v EASYJET AIRLINE CO LTD (NO.2) Get access Reports of Patent, Design and Trade Mark Cases, Volume 123, Issue 7, 2006, Pages 213–257, https://doi.org/10.1093/rpc/2006rpc4 Published: 01 April 2006

LAMBRETTA CLOTHING CO LTD v TEDDY SMITH (UK) LTD

Journal Article LAMBRETTA CLOTHING CO LTD v TEDDY SMITH (UK) LTD Get access Reports of Patent, Design and Trade Mark Cases, Volume 122, Issue 3, 2005, Pages 88–110, https://doi.org/10.1093/rpc/2005rpc6 Published: 01 February 2005

SILVER SPRING MINERAL WATER CO LTD'S TRADE MARK APPLICATION (NO.2)

Journal Article SILVER SPRING MINERAL WATER CO LTD'S TRADE MARK APPLICATION (NO.2) Get access Reports of Patent, Design and Trade Mark Cases, Volume 121, Issue 8, 2004, Pages 279–284, https://doi.org/10.1093/rpc/2004rpc13 Published: 01 April 2004

A. FULTON CO LTD v TOTES ISOTONER (UK) LTD

Journal Article A. FULTON CO LTD v TOTES ISOTONER (UK) LTD Get access Reports of Patent, Design and Trade Mark Cases, Volume 121, Issue 8, 2004, Pages 301–313, https://doi.org/10.1093/rpc/2004rpc16 Published: 01 April 2004

THE INFAMOUS NUT CO LTD'S TRADE MARKS

Journal Article THE INFAMOUS NUT CO LTD'S TRADE MARKS Get access Reports of Patent, Design and Trade Mark Cases, Volume 120, Issue 4, 2003, Pages 126–138, https://doi.org/10.1093/rpc/2003rpc7 Published: 01 February 2003

LAMBRETTA CLOTHING CO LTD v TEDDY SMITH (UK) LTD

Journal Article LAMBRETTA CLOTHING CO LTD v TEDDY SMITH (UK) LTD Get access Reports of Patent, Design and Trade Mark Cases, Volume 120, Issue 21, 2003, Pages 728–756, https://doi.org/10.1093/rpc/2003rpc41 Published: 01 November 2003

SILVER SPRING MINERAL WATER CO LTD'S TRADE MARK APPLICATION

SILVER SPRING MINERAL WATER CO LTD'S TRADE MARK APPLICATION Reports of Patent, Design and Trade Mark Cases, Volume 120, Issue 12, 2003, Pages 405–410, https://doi.org/10.1093/rpc/2003rpc21 Published: 01 June 2003

OLEX FOCAS PTY LTD and Another v SKODAEXPORT CO LTD and Another

OLEX FOCAS PTY LTD and Another v SKODAEXPORT CO LTD and Another

G J COLES & CO LTD v McDONALD

G J COLES & CO LTD v McDONALD

COAL AUTHORITY v HJ BANKS CO LTD HJ BANKS AND CO LTD V (1) COAL AUTHORITY (2) SECRETARY OF STATE OF TRADE AND INDUSTRY

COAL AUTHORITY v HJ BANKS CO LTD HJ BANKS AND CO LTD V (1) COAL AUTHORITY (2) SECRETARY OF STATE OF TRADE AND INDUSTRY

Improving survival of Bifidobacterium for prodn. of foods and drinks using culture of propionic acid fungus and/or cpd.-producing fungus having naphthoquinone ring: MEIJI MILK PROD CO LTD 94.02.18 94JP-043286 (D13) (95.08.29) A23C 9/13, C12N 1/20 (C12N 1/20, C12R 1:01)

Improving survival of Bifidobacterium for prodn. of foods and drinks using culture of propionic acid fungus and/or cpd.-producing fungus having naphthoquinone ring: MEIJI MILK PROD CO LTD 94.02.18 94JP-043286 (D13) (95.08.29) A23C 9/13, C12N 1/20 (C12N 1/20, C12R 1:01)